{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:13Z","timestamp":1792787833479,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82202595"],"award-info":[{"award-number":["No. 82202595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["No. 2021KJ262"],"award-info":[{"award-number":["No. 2021KJ262"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Health Research project","award":["No. TJWJ2021MS010"],"award-info":[{"award-number":["No. TJWJ2021MS010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuroblastoma (NB) is the most prevalent extracranial solid tumor in children. Neutrophils release neutrophil extracellular traps (NETs) following intense or prolonged activation. Neutrophil elastase (ELA2) and citrullinated histone H3 (Cit-H3) are specific markers of NETs. Additionally, neuron-specific enolase (NSE) serves as a biomarker and can be used to monitor the condition of NB progression, assess treatment response, and predict recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study employed a retrospective study design, and all samples were collected prior to bone marrow aspiration for diagnosis. A total of 39 serum samples from patients diagnosed with NB by postoperative pathological bone marrow aspiration were included as the study subjects, and neutrophils, ELA2, and Cit-H3 were detected in the study subjects using ELISA. The blood routine data of 99 patients diagnosed with NB were collected, and these data were from patients different from those of the aforementioned 39 serum samples. And patients were divided into two groups, namely NB patients with positive bone marrow metastasis and those without metastasis, based on the result of bone marrow GD2 immunohistochemical staining. All data were statistically analyzed using IBM SPSS Statistics 26.0 and GraphPad Prism 9.0 software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A positive correlation was identified between NB bone marrow minimal residual disease (MRD) positivity and haematological indices, including interleukin-2 (IL-2) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021), IL-6 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.030), NSE (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and Cit-H3 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). And MRD was positively associated with blood neutrophils in bone marrow (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study demonstrates a significant correlation between NETs and MRDs, and found a positive correlation between bone marrow MRD\n                      <jats:sup>+<\/jats:sup>\n                      and the indicators of IL-2, IL-6, and NSE, as well as a positive correlation with bone marrow neutrophils. And Cit-H3 was identified as a new biomarker and found a positive correlation between Cit-H3 and bone marrow MRD\n                      <jats:sup>+<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-15305-3","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:04:37Z","timestamp":1764119077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bone marrow aspirate Cit-H3 was identified as a novel biomarker of minimal residual disease in neuroblastoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Mengxia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuge","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baocheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"3","key":"15305_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jjco\/hyx176","volume":"48","author":"A Nakagawara","year":"2018","unstructured":"Nakagawara A, Li Y, Izumi H, Muramori K, Inada H, Nishi M. Neuroblastoma. Jpn J Clin Oncol. 2018;48(3):214\u201341.","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"15305_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.sempedsurg.2016.09.007","volume":"25","author":"EA Newman","year":"2016","unstructured":"Newman EA, Nuchtern JG. Recent biologic and genetic advances in neuroblastoma: implications for diagnostic, risk stratification, and treatment strategies. Semin Pediatr Surg. 2016;25(5):257\u201364.","journal-title":"Semin Pediatr Surg"},{"issue":"6282","key":"15305_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.aaf2784","volume":"352","author":"S Turajlic","year":"2016","unstructured":"Turajlic S, Swanton C. Metastasis as an evolutionary process. Science. 2016;352(6282):169\u201375.","journal-title":"Science"},{"key":"15305_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020130","author":"J Badia-Ramentol","year":"2021","unstructured":"Badia-Ramentol J, Linares J, G\u00f3mez-Llonin A, Calon A. Minimal residual disease, metastasis and immunity. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11020130.","journal-title":"Biomolecules"},{"issue":"7","key":"15305_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41571-019-0187-3","volume":"16","author":"K Pantel","year":"2019","unstructured":"Pantel K, Alix-Panabi\u00e8res C. Liquid biopsy and minimal residual disease - latest advances and implications for cure. Nat Rev Clin Oncol. 2019;16(7):409\u201324.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"15305_CR6","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/onc.2015.192","volume":"35","author":"K Pantel","year":"2016","unstructured":"Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene. 2016;35(10):1216\u201324.","journal-title":"Oncogene"},{"key":"15305_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.exphem.2018.06.003","volume":"65","author":"S Sumbal","year":"2018","unstructured":"Sumbal S, Javed A, Afroze B, Zulfiqar HF, Javed F, Noreen S, et al. Circulating tumor DNA in blood: future genomic biomarkers for cancer detection. Exp Hematol. 2018;65:17\u201328.","journal-title":"Exp Hematol"},{"issue":"7","key":"15305_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2217\/imt.11.80","volume":"3","author":"V Pistoia","year":"2011","unstructured":"Pistoia V, Bianchi G, Borgonovo G, Raffaghello L. Cytokines in neuroblastoma: from pathogenesis to treatment. Immunotherapy. 2011;3(7):895\u2013907.","journal-title":"Immunotherapy"},{"issue":"3","key":"15305_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou N, Zhou L, Wang J, Zhou Y, Zhang T, et al. IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor. Nat Immunol. 2021;22(3):358\u201369.","journal-title":"Nat Immunol"},{"issue":"5","key":"15305_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2022.04.004","volume":"40","author":"Y Hailemichael","year":"2022","unstructured":"Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel S-E, Daher M, et al. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell. 2022;40(5):509.","journal-title":"Cancer Cell"},{"issue":"3","key":"15305_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","volume":"57","author":"AN Shouse","year":"2024","unstructured":"Shouse AN, LaPorte KM, Malek TR. Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer. Immunity. 2024;57(3):414\u201328.","journal-title":"Immunity"},{"key":"15305_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2025.01.001","author":"S Wu","year":"2025","unstructured":"Wu S, Cao Z, Lu R, Zhang Z, Sethi G, You Y. Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy. Cytokine Growth Factor Rev. 2025. https:\/\/doi.org\/10.1016\/j.cytogfr.2025.01.001.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"15305_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127\u201348.","journal-title":"Int Immunol"},{"key":"15305_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01749","volume":"11","author":"MT Masucci","year":"2020","unstructured":"Masucci MT, Minopoli M, Del Vecchio S, Carriero MV. The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis. Front Immunol. 2020;11:1749.","journal-title":"Front Immunol"},{"issue":"21","key":"15305_CR15","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1182\/blood.2021013565","volume":"139","author":"EGG Sprenkeler","year":"2022","unstructured":"Sprenkeler EGG, Tool ATJ, Henriet SSV, van Bruggen R, Kuijpers TW. Formation of neutrophil extracellular traps requires actin cytoskeleton rearrangements. Blood. 2022;139(21):3166\u201380.","journal-title":"Blood"},{"issue":"2","key":"15305_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jlb.59.2.229","volume":"59","author":"H Takei","year":"1996","unstructured":"Takei H, Araki A, Watanabe H, Ichinose A, Sendo F. Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosis. J Leukoc Biol. 1996;59(2):229\u201340.","journal-title":"J Leukoc Biol"},{"issue":"5663","key":"15305_CR17","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532\u20135.","journal-title":"Science"},{"key":"15305_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.913028","volume":"13","author":"Y He","year":"2022","unstructured":"He Y, Liu J, Chen Y, Yan L, Wu J. Neutrophil extracellular traps in Candida albicans infection. Front Immunol. 2022;13:913028.","journal-title":"Front Immunol"},{"issue":"1","key":"15305_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/JLB.4A0119-009RR","volume":"107","author":"JC Silva","year":"2020","unstructured":"Silva JC, Rodrigues NC, Thompson-Souza GA, Muniz VS, Neves JS, Figueiredo RT. Mac-1 triggers neutrophil DNA extracellular trap formation to Aspergillus fumigatus independently of PAD4 histone citrullination. J Leukoc Biol. 2020;107(1):69\u201383.","journal-title":"J Leukoc Biol"},{"key":"15305_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.24437","author":"EF Kenny","year":"2017","unstructured":"Kenny EF, Herzig A, Kr\u00fcger R, Muth A, Mondal S, Thompson PR, et al. Diverse stimuli engage different neutrophil extracellular trap pathways. Elife. 2017. https:\/\/doi.org\/10.7554\/eLife.24437.","journal-title":"Elife"},{"key":"15305_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","volume":"36","author":"HR Thiam","year":"2020","unstructured":"Thiam HR, Wong SL, Wagner DD, Waterman CM. Cellular mechanisms of NETosis. Annu Rev Cell Dev Biol. 2020;36:191\u2013218.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"15305_CR22","doi-asserted-by":"publisher","unstructured":"Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11). https:\/\/doi.org\/10.1172\/jci.insight.138999.","DOI":"10.1172\/jci.insight.138999"},{"key":"15305_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210265","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Niu R, Zhao L, Wang Y, Liu G. Mechanisms of neutrophil extracellular trap formation and regulation in cancers. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241210265.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"15305_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28492-5","volume":"13","author":"X Xia","year":"2022","unstructured":"Xia X, Zhang Z, Zhu C, Ni B, Wang S, Yang S, et al. Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications. Nat Commun. 2022;13(1):1017.","journal-title":"Nat Commun"},{"issue":"3","key":"15305_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3892\/ol.2023.13955","volume":"26","author":"S Inoue","year":"2023","unstructured":"Inoue S, Win KHN, Mon CY, Fujikawa T, Hyodo S, Uemura S, et al. Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse\/regrowth in a patient with high\u2013risk neuroblastoma: A case report. Oncol Lett. 2023;26(3):369.","journal-title":"Oncol Lett"},{"key":"15305_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00455","volume":"9","author":"S Uemura","year":"2019","unstructured":"Uemura S, Ishida T, Thwin KKM, Yamamoto N, Tamura A, Kishimoto K, et al. Dynamics of minimal residual disease in neuroblastoma patients. Front Oncol. 2019;9:455.","journal-title":"Front Oncol"},{"issue":"1","key":"15305_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02913-9","volume":"42","author":"MC Stip","year":"2023","unstructured":"Stip MC, Teeuwen L, Dierselhuis MP, Leusen JHW, Krijgsman D. Targeting the myeloid microenvironment in neuroblastoma. J Exp Clin Cancer Res. 2023;42(1):337.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"15305_CR28","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/sj.bjc.6605029","volume":"100","author":"K Beiske","year":"2009","unstructured":"Beiske K, Burchill SA, Cheung IY, Hiyama E, Seeger RC, Cohn SL, et al. Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the international neuroblastoma risk group task force. Br J Cancer. 2009;100(10):1627\u201337.","journal-title":"Br J Cancer"},{"issue":"12","key":"15305_CR29","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1007\/s00431-022-04617-2","volume":"181","author":"Q Sun","year":"2022","unstructured":"Sun Q, Chen Y, Jin Q, Yuan X. A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma. Eur J Pediatr. 2022;181(12):4135\u201347.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"15305_CR30","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2299","volume":"15","author":"S Uemura","year":"2021","unstructured":"Uemura S, Lin KS, Mon Thwin KK, Nakatani N, Ishida T, Yamamoto N, et al. Limited correlation between tumor markers and minimal residual disease detected by seven neuroblastoma\u2011associated mRNAs in high\u2011risk neuroblastoma patients. Mol Clin Oncol. 2021;15(1):137.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"15305_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-023-01508-6","volume":"49","author":"J Li","year":"2023","unstructured":"Li J, Qi Z, Chen M, Wang J, Liu X. Clinical value of combined serum CA125, NSE and 24-hour urine VMA for the prediction of recurrence in children with neuroblastoma. Ital J Pediatr. 2023;49(1):102.","journal-title":"Ital J Pediatr"},{"issue":"8346","key":"15305_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(83)90342-2","volume":"2","author":"PM Zeltzer","year":"1983","unstructured":"Zeltzer PM, Marangos PJ, Parma AM, Sather H, Dalton A, Hammond D, et al. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the children\u2019s cancer study group. Lancet. 1983;2(8346):361\u20133.","journal-title":"Lancet"},{"issue":"6","key":"15305_CR33","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/1097-0142(19860315)57:6<1230::AID-CNCR2820570628>3.0.CO;2-#","volume":"57","author":"PM Zeltzer","year":"1986","unstructured":"Zeltzer PM, Marangos PJ, Evans AE, Schneider SL. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer. 1986;57(6):1230\u20134.","journal-title":"Cancer"},{"key":"15305_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-94-017-7215-0_9","volume":"867","author":"MA Isgr\u00f2","year":"2015","unstructured":"Isgr\u00f2 MA, Bottoni P, Scatena R. Neuron-Specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125\u201343.","journal-title":"Adv Exp Med Biol"},{"key":"15305_CR35","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903048911","author":"BH Yamane","year":"2009","unstructured":"Yamane BH, Hank JA, Albertini MR, Sondel PM. The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma. Expert Opin Investig Drugs. 2009. https:\/\/doi.org\/10.1517\/13543780903048911.","journal-title":"Expert Opin Investig Drugs"},{"issue":"14","key":"15305_CR36","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJMoa2210859","volume":"388","author":"F Del Bufalo","year":"2023","unstructured":"Del Bufalo F, De Angelis B, Caruana I, Del Baldo G, De Ioris MA, Serra A, et al. GD2-CART01 for relapsed or refractory high-risk neuroblastoma. N Engl J Med. 2023;388(14):1284\u201395.","journal-title":"N Engl J Med"},{"issue":"2","key":"15305_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41388-023-02885-2","volume":"43","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Qi F, Zhou C, Ji J, Jiang J, Wang C, et al. VPS35 promotes gastric cancer progression through integrin\/FAK\/SRC signalling-mediated IL-6\/STAT3 pathway activation in a YAP-dependent manner. Oncogene. 2024;43(2):106\u201322.","journal-title":"Oncogene"},{"issue":"2","key":"15305_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","volume":"141","author":"X Yao","year":"2014","unstructured":"Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014;141(2):125\u201339.","journal-title":"Pharmacol Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15305-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T01:53:37Z","timestamp":1767059617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15305-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15305"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15305-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the revised Declaration of Helsinki. Written informed consents were obtained from each patient, and the study was approved by the Tianjin Medical University Cancer Institute and Hospital (NO. bc2022216).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1919"}}